SBWire

Morocco has looked like an island in the storm in recent years, enjoying relative prosperity while much of the rest of North Africa and the Middle East (MENA) has become embroiled in revolution and political upheaval. As Egypt, Tunisia, Libya and Syria all became caught up in the Arab Spring of 2011 and its aftermath, Morocco calmly elected a new government, enjoyed the support of the US and the fruits of a modest but steady period of economic growth. However, the new Islamist government of Abdelilah Benkirane that was elected in November 2011 has inherited a number of problems from its predecessor and was forced to halve its GDP growth forecast in early 2012 to 3%. Drought has since upset the country’s important agricultural sector, which is normally expected to contribute 15% of GDP through wheat and vegetable harvests largely destined for export. Tourism has also fallen as a result of more frugal spending from potential holidaymakers living in the eurozone and continued Western unease about the safety and stability of the wider MENA region.

The latest data available from operators and the regulator, Subtel, show that Chile still has considerable potential for growth - despite having passed the 150% penetration mark in terms of mobile subscribers. The prospect of LTE/4G technology should help drive the market further, encouraging subscribers to upgrade handsets and opt for more expensive data packages - although we do expect that there will be considerable downward pressure on pricing as the key operators compete for market share. In terms of broadband, mobile broadband subscriber numbers more than double wireline broadband subscribers, and the former posted impressive growth in 2012. Mobile broadband is particularly suited to Chile, as geographical obstacles and a dispersed population make investment in wireline infrastructure an expensive venture for telecoms operators. In many parts of the country, government-funded network expansion, such as Subtel's plans for over 1,000 Wi-Fi spots, are the only means of increasing internet access where private investment does not make good business sense. Over the course of our five-year forecast period, we expect to see double-digit growth in terms of the number of 3G and 4G mobile subscribers; declines in fixed-line services; and low single-digit growth in wireline broadband.

Our baseline scenario sees relatively solid growth over the coming quarters, with real GDP forecast to expand 3.3% and 3.8% in 2013 and 2014, respectively.

The Brazil Tourism Report examines the significant long-term potential being offered by the local tourism industry, especially with the country to host first the FIFA Football World Cup in 2014 and then the Olympic Games in Rio de Janeiro in 2016, but also flags short-term concerns about the lack of adequate nationwide airport infrastructure and hotel room supply in major Brazilian cities, both of which pose a clear challenge to the near-term future development of the local tourism sector.

The accompanying tables present the latest economic data and five-year forecast scenario for the country's banking system. Also included is SWOT analysis of the commercial banking system as a whole.

BMI's Croatia Tourism Report looks at the long-term potential offered by the country's tourism industry, which is gradually showing signs of recovery following the global credit crunch. Inbound travel is expected to show consistent growth, although domestic economy limitations may depress outbound travel.

GlobalData has released its new PharmaPoint Drug Evaluation report, "Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022". Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the 'gold-standard' bisphosphonates will lose patent protection by end-of-year 2013, flooding the marketplace with less expensive generic versions of these physician-preferred medications. Additionally, Eli Lilly's blockbuster Evista, the only available SERM in the US, will lose patent protection in 2014, flooding the market with yet more affordable generic options. Also during the forecast period covered by this report, osteoporosis drug development research will lead to the launches of a wave of novel anabolic drugs with greater efficacy and safety, causing a major market shift away from anti-resorptive drugs. The number of companies vying for patient share will shrink by as much as 50%, as established players exit the market or acquire smaller players. Lastly, the aging of the population in developed markets will result in a larger patient pool.

Stribild (HIV) - Forecast and Market Analysis to 2022

GlobalData's new report, "Czech Republic Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Dental Biomaterials, Crowns and Bridges and Others" provides key market data on the Czech Republic Dental Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Dental Implants, Dental Radiology Equipment, Crowns and Bridges, Dental Chairs and Equipment, CAD/CAM Dental Systems, Dental Biomaterials and Dental Lasers. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData has released its new PharmaPoint Drug Evaluation report, "Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022". The recent approvals of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J's Zytiga (abiraterone acetate) and Medivation/Astellas' Xtandi (enzalutamide) will drive strong market growth over the next decade. These safe and orally administered treatments will provide safety and convenience benefits over the current standard of care, chemotherapy with docetaxel, while prolonging the overall survival of patients with mCRPC. The December 12, 2012 FDA approval of Zytiga for the added indication of chemotherapy-naive mCRPC marks the onset of a new treatment paradigm for the disease, in which chemotherapy is relegated to second-line therapy and beyond. For patients with earlier-stage prostate cancer, androgen deprivation therapy with LHRH agonists and first-generation antiandrogens remains the standard of care for suppressing testosterone levels and temporarily controlling the disease.

Turkey will remain heavily dependent upon oil and gas imports for the foreseeable future. However, its role as a critical energy transit hub between Western and Emerging Europe, the Middle East, the Caspian and Russia provides it with a unique form of leverage and makes it indispensable as a key player in the global energy market. In these contexts, its rapprochement with Israel and the possibility of permanent truce with the PKK are significant tactical successes in its strategy towards all-encompassing energy security. There is also upside potential to the country's domestic energy production in the form of Black Sea reserves and unconventionals, including shale, although it is too early for either to be factored into our forecasts. Mounting investment into exploration activities underscores the government's growing commitment to increasing its own domestic resource base.

Australia Uranium Mining Market Overview and Forecast to 2020: Trends, Major Projects, and Competitive Landscape

European Nuclear Medicine / Radiopharmaceuticals Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017]

A competitively priced comprehensive overview of the key categories in the soft drinks market.

Published by Canadean, Global Beverage Forecasts provides consumption trends from 1999 to 2011 actual, 2012 provisional and 2013 to 2018 forecasts for key beverage categories.

GlobalData's energy offering, "Oil and Gas Exploration and Production Outlook in US Texas to 2016 - Production Analysis, Forecasts and Details of Major Crude Oil and Natural Gas Blocks and Fields" is the essential source for industry data and information relating to the exploration and production industry in US Texas. It provides asset level information related to active and planned oil and gas fields and exploration blocks in US Texas. The profiles of major companies operating in the upstream industry in US Texas are included in the report. The latest news and deals relating to the sector are also provided and analyzed.

GlobalData's energy offering, "Oil and Gas Exploration and Production Outlook in US Colorado to 2016 - Production Analysis, Forecasts and Details of Major Crude Oil and Natural Gas Blocks and Fields" is the essential source for industry data and information relating to the exploration and production industry in US Colorado. It provides asset level information related to active and planned oil and gas fields and exploration blocks in US Colorado. The profiles of major companies operating in the upstream industry in US Colorado are included in the report. The latest news and deals relating to the sector are also provided and analyzed.

Global Markets Direct's, 'Metastatic Colorectal Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Colorectal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Colorectal Cancer. Metastatic Colorectal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

The report provides in-depth market analysis, information and insights, including:

Global Market Direct's pharmaceuticals report, "Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2013" provides data on the Takeda Pharmaceutical Company Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

American Children's Cancer Association (ACCA) will now be accepting your car (and other vehicle) donations, in Deleware.

Brain Hemorrhage - Pipeline Review, H1 2013

According to the International Monetary Fund (IMF), Mozambique ranked among the fastest-growing economies in the world in 2011. This was partly due to the nation exporting coal for the first time which placed it on the list of global exporters of mineral resources. Furthermore, the discovery of offshore natural gas garnered international interest and investment. Within this economic context, the insurance industry benefited and registered a CAGR of 28.6% during the review period (2008-2012).

The convenience offered by credit cards to make payments is exploited for fraudulent activities, resulting in the loss of millions of dollars every year around the world. In order to control and limit these risks and losses, a proper risk management framework is required to be established. Over the last five years, card issuers, acquirers, merchants and network operators have adopted and implemented a host of security measures, regulations and business strategies to lower the chances of fraud and credit losses. However, they are limited by several macroeconomic, regulatory and operational challenges. The management of risk associated with credit cards requires continuous efforts from every participant of the card payment industry. However, to do so, development of a best practice framework is of utmost importance. A well developed framework facilitates a better understanding of risks and areas which require attention from the intended parties, and formulates strategies to address them.

The Danish construction industry valued at DKK191.8 billion (US$35.9 billion) in 2012, recording a CAGR of -3.31% during the review period. All construction markets registered negative growth in this period. This is largely a result of the slowing down of the economy following the financial crisis. Residential construction constituted the largest market within the construction industry, accounting for a 46.8% share of industry output in 2012. However, the market was also among the worst performing markets and recorded a CAGR of -3.88% during the review period. Despite a decline in property prices during the past few years, they remain considerably higher compared with neighboring countries, leaving the residential market in a fragile situation. Timetric expects the residential construction market to record positive growth in 2014 with a CAGR of 1.44% over the forecast period, after recording a decline of 0.3% in 2013.